Cilia R. Pothast

Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19

Anna H.E. Roukens, Cilia R. Pothast, Marion König et al. · Nature Immunology · 2021 · 130 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Simultaneous Deletion of Endogenous TCRαβ for TCR Gene Therapy Creates an Improved and Safe Cellular Therapeutic

Laura T. Morton, Rogier M. Reijmers, Anne K. Wouters et al. · Molecular Therapy · 2019 · 69 citations · Full text

Life Sciences, Genetics, Immunology +17

SARS-CoV-2-specific CD4+ and CD8+ T cell responses can originate from cross-reactive CMV-specific T cells

Cilia R. Pothast, Romy C. Dijkland, Melissa Thaler et al. · eLife · 2022 · 38 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial

Margaretha Prins, Geert V.T. Roozen, Cilia R. Pothast et al. · npj Vaccines · 2024 · 32 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Human T cells recognize HLA-DP–bound peptides in two orientations

Sebastian Klobuch, Jia Jia Lim, Peter van Balen et al. · Proceedings of the National Academy of Sciences · 2022 · 28 citations · Full text

Life Sciences, Immunology, Molecular Biology +17